287 related articles for article (PubMed ID: 18613418)
1. Influence of risk factors for metabolic syndrome and non-alcoholic fatty liver disease on the progression and prognosis of hepatocellular carcinoma.
Takamatsu S; Noguchi N; Kudoh A; Nakamura N; Kawamura T; Teramoto K; Igari T; Arii S
Hepatogastroenterology; 2008; 55(82-83):609-14. PubMed ID: 18613418
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathological features of hepatocellular carcinomas (HCCs) arising in patients without chronic viral infection or alcohol abuse: a retrospective study of patients undergoing hepatic resection.
Yokoi Y; Suzuki S; Baba S; Inaba K; Konno H; Nakamura S
J Gastroenterol; 2005 Mar; 40(3):274-82. PubMed ID: 15830287
[TBL] [Abstract][Full Text] [Related]
3. Features and outcome after liver resection for non-B non-C hepatocellular carcinoma.
Kaneda K; Kubo S; Tanaka H; Takemura S; Ohba K; Uenishi T; Kodai S; Shinkawa H; Urata Y; Sakae M; Yamamoto T; Suehiro S
Hepatogastroenterology; 2012 Sep; 59(118):1889-92. PubMed ID: 22819910
[TBL] [Abstract][Full Text] [Related]
4. Clinical features of patients with HCC who are negative for both HBV and HCV markers.
Watabe H; Shiratori Y; Tateishi R; Fujishima T; Akamatsu M; Koike Y; Obi S; Hamamura K; Sato S; Teratani T; Shiina S; Omata M
Hepatogastroenterology; 2003; 50(54):2157-60. PubMed ID: 14696486
[TBL] [Abstract][Full Text] [Related]
5. Clinical characteristics of non-B non-C hepatocellular carcinoma: a single-center retrospective study.
Kim SK; Marusawa H; Eso Y; Nishikawa H; Ueda Y; Kita R; Kimura T; Chiba T; Osaki Y; Kudo M
Digestion; 2011; 84 Suppl 1():43-9. PubMed ID: 22156485
[TBL] [Abstract][Full Text] [Related]
6. Non-alcoholic steatohepatitis (NASH) and hepatocellular carcinoma.
Cuadrado A; Orive A; García-Suárez C; Domínguez A; Fernández-Escalante JC; Crespo J; Pons-Romero F
Obes Surg; 2005 Mar; 15(3):442-6. PubMed ID: 15826485
[TBL] [Abstract][Full Text] [Related]
7. Impact of Hepatic Steatosis on Disease-Free Survival in Patients with Non-B Non-C Hepatocellular Carcinoma Undergoing Hepatic Resection.
Nishio T; Hatano E; Sakurai T; Taura K; Okuno M; Kasai Y; Seo S; Yasuchika K; Mori A; Kaido T; Uemoto S
Ann Surg Oncol; 2015 Jul; 22(7):2226-34. PubMed ID: 25395147
[TBL] [Abstract][Full Text] [Related]
8. Primary liver cancers with nonalcoholic steatohepatitis.
Hashizume H; Sato K; Takagi H; Hirokawa T; Kojima A; Sohara N; Kakizaki S; Mochida Y; Shimura T; Sunose Y; Ohwada S; Mori M
Eur J Gastroenterol Hepatol; 2007 Oct; 19(10):827-34. PubMed ID: 17873605
[TBL] [Abstract][Full Text] [Related]
9. Outcomes of curative treatment for hepatocellular cancer in nonalcoholic steatohepatitis versus hepatitis C and alcoholic liver disease.
Reddy SK; Steel JL; Chen HW; DeMateo DJ; Cardinal J; Behari J; Humar A; Marsh JW; Geller DA; Tsung A
Hepatology; 2012 Jun; 55(6):1809-19. PubMed ID: 22183968
[TBL] [Abstract][Full Text] [Related]
10. Obesity and diabetes as a risk factor for hepatocellular carcinoma.
Regimbeau JM; Colombat M; Mognol P; Durand F; Abdalla E; Degott C; Degos F; Farges O; Belghiti J
Liver Transpl; 2004 Feb; 10(2 Suppl 1):S69-73. PubMed ID: 14762843
[TBL] [Abstract][Full Text] [Related]
11. Review article: steatosis, the metabolic syndrome and cancer.
Bugianesi E
Aliment Pharmacol Ther; 2005 Nov; 22 Suppl 2():40-3. PubMed ID: 16225471
[TBL] [Abstract][Full Text] [Related]
12. Etiological factor of hepatocellular carcinoma in Italy.
Stroffolini T
Minerva Gastroenterol Dietol; 2005 Mar; 51(1):1-5. PubMed ID: 15756142
[TBL] [Abstract][Full Text] [Related]
13. Surgical treatment of hepatocellular carcinoma associated with the metabolic syndrome.
Cauchy F; Zalinski S; Dokmak S; Fuks D; Farges O; Castera L; Paradis V; Belghiti J
Br J Surg; 2013 Jan; 100(1):113-21. PubMed ID: 23147992
[TBL] [Abstract][Full Text] [Related]
14. Significant correlations between severe fatty liver and risk factors for metabolic syndrome.
Hsiao PJ; Kuo KK; Shin SJ; Yang YH; Lin WY; Yang JF; Chiu CC; Chuang WL; Tsai TR; Yu ML
J Gastroenterol Hepatol; 2007 Dec; 22(12):2118-23. PubMed ID: 18031368
[TBL] [Abstract][Full Text] [Related]
15. Liver transplantation in patients with nonalcoholic steatohepatitis-related hepatocellular carcinoma.
Malik SM; Gupte PA; de Vera ME; Ahmad J
Clin Gastroenterol Hepatol; 2009 Jul; 7(7):800-6. PubMed ID: 19281869
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathological characteristics of patients with non-B non-C hepatocellular carcinoma: a special reference to metabolic syndrome.
Imura S; Shimada M; Utsunomiya T; Morine Y; Ikemoto T; Mori H; Arakawa Y; Kanamoto M; Iwahashi S; Miyake H
Hepatogastroenterology; 2014; 61(129):129-35. PubMed ID: 24895808
[TBL] [Abstract][Full Text] [Related]
17. Role of hepatitis B virus infection in the prognosis after hepatectomy for hepatocellular carcinoma in patients with cirrhosis: a Western dual-center experience.
Cescon M; Cucchetti A; Grazi GL; Ferrero A; Viganò L; Ercolani G; Ravaioli M; Zanello M; Andreone P; Capussotti L; Pinna AD
Arch Surg; 2009 Oct; 144(10):906-13. PubMed ID: 19841357
[TBL] [Abstract][Full Text] [Related]
18. Metabolic syndrome is associated with severe fibrosis in chronic viral hepatitis and non-alcoholic steatohepatitis.
Tsochatzis E; Papatheodoridis GV; Manesis EK; Kafiri G; Tiniakos DG; Archimandritis AJ
Aliment Pharmacol Ther; 2008 Jan; 27(1):80-9. PubMed ID: 17919273
[TBL] [Abstract][Full Text] [Related]
19. Review article: the metabolic syndrome and non-alcoholic fatty liver disease.
Loria P; Lonardo A; Carulli L; Verrone AM; Ricchi M; Lombardini S; Rudilosso A; Ballestri S; Carulli N
Aliment Pharmacol Ther; 2005 Nov; 22 Suppl 2():31-6. PubMed ID: 16225469
[TBL] [Abstract][Full Text] [Related]
20. The preoperative positivity for serum hepatitis B e antigen did not affect overall survival after curative resection of hepatitis B virus-related hepatocellular carcinoma.
Choi GH; Kim DH; Choi SB; Kang CM; Kim KS; Choi JS; Lee WJ; Han KH; Chon CY; Kim BR
J Gastroenterol Hepatol; 2009 Mar; 24(3):391-8. PubMed ID: 19032452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]